Govt recalls ulcers capsules after mix-up during packaging
By Lucy Mumbi |
The Board emphasised that it remains committed to protecting the health of the public.
The Pharmacy and Poisons Board (PPB) has issued a recall of a batch of Esomeprazole drugs manufactured by Laborate Pharmaceutical India Limited.
Esomeprazole is used to treat certain stomach and oesophagus problems (such as acid reflux and ulcers), by decreasing the amount of acid the stomach generates.
Keep reading
- State fights fake drugs with advanced on-site screening tools
- Public warned over unregistered and substandard cancer drug in the market
- Pharmacy Board orders withholding of drug used to relieve menstrual pain over contamination concerns
- PPB recalls cancer drug Flurasted 500 (5-Fluorouracil) Injection, Batch No. HHP24017
PPB, on Tuesday, said the Esomeprazole Magnesium Delayed-Release Capsules 40 mg (Batch No. SPZ-302 of S-PRAZO) were ordered off the market following complaints about a mix-up in blister strips.
The board's Chief Executive Officer, Fred Siyoi, said, “The product batch is being recalled following a market complaint regarding the mix-up of blister strips; some boxes were found to contain two different blister strips, i.e S-Prazo capsules and Donystatin Tablets, within the same outer carton."
An officer from the Pharmacy and Poisons Board (PPB) inspects drugs at a pharmacy. (X/PPB)
S-Prazo (Esomeprazole Magnesium) is used to reduce stomach acid, erosive oesophagitis, stomach ulcers, and Zollinger-Ellison syndrome, while Donystatin is an antifungal medication used to treat fungal infections like thrush, specifically targeting fungi rather than managing acid levels.
Siyoi urged all pharmaceutical outlets, healthcare facilities, professionals, and the public to immediately cease the distribution, sale, issuance, or use of this batch and to return the affected product to the nearest healthcare facility or suppliers.
ulcers.
The Board emphasised that it remains committed to protecting the health of the public and encourages the public to promptly report any suspected cases of sub-standard medicines or adverse drug reactions.
Reports may be made to the nearest healthcare facility or the Pharmacy and Poisons Board through its website: https://pv.pharmacyboardkenya.org/users/mpublic, USSD code: *271#, email: [email protected] or [email protected], or through telephone No. 0795743049.
Reader comments
Follow Us and Stay Connected!
We'd love for you to join our community and stay updated with our latest stories and updates. Follow us on our social media channels and be part of the conversation!
Let's stay connected and keep the dialogue going!
Latest News For You
